Assessment of cardiac diastolic dysfunction in HIV-infected people without cardiovascular symptoms in China

International Journal of STD and AIDS

Volumn 21, Issue 12, 2010, Pages 814-818

  Luo, L ^a   Ye, Y ^b   Liu, Z ^a   Zuo, L ^a   Li, Y ^a   Han, Y ^a   Qiu, Z ^a   Li, L ^b   Zeng, Y ^b   Li, T S ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Diastolic dysfunction; Echocardiography; HAART; HIV; Zidovudine

Indexed keywords

ZIDOVUDINE;

ADULT; AIDS PATIENT; ARTICLE; CARDIOVASCULAR SYMPTOM; CHINA; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TISSUE DOPPLER IMAGING;

ADULT; ASYMPTOMATIC DISEASES; CHINA; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE, DIASTOLIC; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE;

EID: 79551713859     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2010.010168     Document Type: Article

References (30)

1. Levy WS, Simon GL, Rios JC, Ross AM. Prevalence of cardiac abnormalities in human immunodeficiency virus infection. Am J Cardiol 1989;63:86-89 (Pubitemid 19018945)
2. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. N Engl J Med 1998;339:1093-9 (Pubitemid 28465756)
3. Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet 2000;356:1423-30
4. Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003;348:702-10 (Pubitemid 36237039)
5. Friis-Møller N, Weber R, Reiss P, et al. Cardiovascular risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD Study. AIDS 2003;17:1179-93 (Pubitemid 36667761)
6. Redfield MM, Jacobsen SJ, Burnett JR, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003;289:194-202 (Pubitemid 36068707)
7. Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 2001;24:5-10 (Pubitemid 32104211)
8. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997;30:1527-33 (Pubitemid 27486472)
9. Murata M, Iwanaga S, Tamura Y, et al. A real-time three-dimensional echocardiographic quantitative analysis of left atrial function in left ventricular diastolic dysfunction. Am J Cardiol 2008;102:1097-1102
10. Khouri SJ, Maly GT, Suh DD, Walsh TE. A practical approach to the echocardiographic evaluation of diastolic function. J Am Soc Echocardiogr 2004;17:290-7 (Pubitemid 38879266)
11. Strand A, Kjeldsen SE, Gudmundsdottir H, Os I, Smith G, Bjørnerheim R. Tissue Doppler imaging describes diastolic function in men prone to develop hypertension over twenty years. Eur J Echocardiogr 2008;9:34-9 (Pubitemid 351664805)
12. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16 (Pubitemid 35403784)
13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486-97
14. Nayak G, Ferguson M, Tribble DR, et al. Cardiac diastolic dysfunction is prevalent in HIV-infected patients. AIDS Patient Care STDS 2009;23:231-8
15. Cardoso JS, Moura B, Martins L, Mota-Miranda A, Rocha F, Lecour H. Left ventricular dysfunction in human immunodeficiency virus (HIV)-infected patients. Int J Cardiol 1998;63:37-45 (Pubitemid 28060224)
16. Longo-Mbenza B, Seghers LV, Vita EK, Tonduangu K, Bayekula M. Assessment of ventricular diastolic function in AIDS patients from Congo: a Doppler echocardiographic study. Heart 1998;80:184-9 (Pubitemid 28389482)
17. Meng Q, Lima JA, Lai H, et al. Use of HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction. J Acquir Immune Defic Syndr 2002;30:306-10 (Pubitemid 34774078)
18. Garcia MJ, Thomas JD, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 1998;32:865-75 (Pubitemid 28459571)
19. Karavidas A, Foukarakis M, Lazaros G, et al. Assessment of cardiac function with Doppler tissue imaging in asymptomatic HIV-infected patients. Int J STD AIDS 2008;19:227-31 (Pubitemid 351738770)
20. Schuster I, Thöni GJ, Edérhy S, et al. Subclinical cardiac abnormalities in human immunodeficiency virus - infected men receiving antiretroviral therapy. Am J Cardiol 2008;101:1213-7
21. Barbaro G, Barbarini G, Di Lorenzo G. Early impairment of systolic and diastolic function in asymptomatic HIV-positive patients: a multicenter echocardiographic and echo-Doppler study. AIDS Res Hum Retroviruses 1996;12:1559-63 (Pubitemid 26366915)
22. Mu H, Chai H, Lin PH, Yao Q, Chen C. Current update on HIV-associated vascular disease and endothelial dysfunction. World J Surg 2007;31:632-43 (Pubitemid 46496230)
23. Eerens F, Van J, Peetermans WE. A probable primary HIV infection associated with acute non-specific myocarditis causing severe dilated cardiomyopathy. Acta Clin Belg 1999;54:220-22 (Pubitemid 29472638)
24. Pugliese A, Isnardi D, Saini A, Scarabelli T, Raddino R, Torre D. Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect 2000;40:282-4 (Pubitemid 30447185)
25. Lewis W. Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy. Antivir Ther 2005;10(Suppl 2):13-27
26. Lund KC, Wallace KB. Direct effects of nucleoside reverse transcriptase inhibitors on rat cardiac mitochondrial bioenergetics. Mitochondrion 2004;4:193-202 (Pubitemid 39549809)
27. Maagaard A, Kvale D. Long term adverse effects related to nucleoside reverse transcriptase inhibitors: clinical impact of mitochondrial toxicity. Scand J Infect Dis 2009;41:808-17
28. Lewis W, Kohler JJ, Hosseini SH, et al. Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis. AIDS 2006;20:675-84 (Pubitemid 43884294)
29. Negredo E, Miró O, Rodríguez-Santiago B, et al. Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA). Clin Infect Dis 2009;49:892-900
30. D:A:D Study Group, Sabin CA, Worm SW, Weber R, et al. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration. Lancet 2008;371:1417-26